Valcyte, Valganciofer 450 mg – 60 mg

Valcyte, containing 450 mg of Valganciclovir, is an antiviral medication used to inhibit the replication of cytomegalovirus (CMV) by interfering with viral DNA synthesis. It is commonly prescribed for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for the prevention of CMV infection in organ transplant recipients.

Indications:

• Treatment of CMV retinitis in patients with AIDS.

• Prevention of CMV infection in organ transplant patients.

Dosage and Administration:

• Dosage may vary depending on the patient’s specific condition and medical history.

• Tablets should be taken orally, with or without food.

• Follow your healthcare provider’s instructions regarding dose and duration of treatment.

• Do not double the dose to make up for a missed one. If you overdose, seek immediate medical attention.

Possible Side Effects:

• Nausea, vomiting, diarrhea.

• Headache, fatigue.

• Reduced blood cell counts (anemia, neutropenia, thrombocytopenia).

• Kidney problems.

Warnings and Precautions:

• Regularly monitor blood cell counts as directed by your healthcare provider.

• Report any signs of infection immediately.

• Use effective contraception during treatment, as Valganciclovir may harm an unborn baby.

• Consult your doctor before use if you are pregnant, breastfeeding, or planning to conceive.

Storage Instructions:

• Store below 25°C in the original packaging to protect from moisture.

• Keep out of the sight and reach of children.